Nov 14 (Reuters)-
Delta-Fly Pharma, Inc.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2025 Sep 30, 2024 Mar 31, 2026
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Operating loss 831 mln loss 916 mln loss 1.50
Recurring loss 840 mln loss 915 mln loss 1.51
Net loss 841 mln loss 917 mln loss 1.51
EPS loss 77.04 yen loss 111.44 yen loss 155.45 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Delta-Fly Pharma, Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4598.T